Biopolym. Cell. 2012; 28(3):234-238 .
http://dx.doi.org/10.7124/bc.000054
Genomics, Transcriptomics and Proteomics
Amphiphysin 1 and 2 interact with latent membrane protein 2A of Epstein-Barr virus and regulate its exosomal secretion
1Dergai O. V., 1Dergai M. V., 1Skrypkina I. Ya., 1Tsyba L. O., 1Yaruchik A. M., 1Rynditch A. V.
  1. State Key Laboratory of Molecular and Cellular Biology
    Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680

Abstract

Latent membrane protein 2A (LMP2A) of Epstein-Barr virusisimplicated in the regulation of viral latency. The aim of the current study was to identify proteins interacting with proline-rich motifs of LMP2A. Methods. In silico prediction with Scansite allowed to recognize amphiphysin 1 (Amph1) as a binding partner of LMP2A. Molecular cloning techniques, site-directed mutagenesis, in vitro binding assay made it possible to study the interaction interface of Amph1/LMP2A complex. Sequential centrifugation steps were used to isolate an exosomal fraction. Results. LMP2A but not LMP2DNT mutant has been found to bind the SH3 domain of Amph1 via three distinct proline-rich motifs located in the N-terminal tail. All three motifs seem to be interchangeable as the presence of at least one of them was sufficient to mediate LMP2A/Amph1 interaction. Furthermore, the binding of LMP2A to Amph1 and related protein amphiphysin 2 was demonstrated by co-immunoprecipitation of endogenous complexes. We have found that inability of LMP2A mutant to bind Amph1 leads to the vanishing of the viral protein from the exosomal fraction. Conclusions. The latent membrane protein 2A of Epstein-Barr virus forms complexes with endocytic adaptor proteins Amph1 and Amph2. Described interaction might be involved in the regulation of intracellular traffic and secretion of LMP2A.
Keywords: EBV, LMP2A, Amphiphysin, exosomes
Full text: (PDF, in English)

References

[1] Kieff E., Liebowitz D. Epstein-Barr virus and its replication Fields virology / Eds B. N. Fields, D. M. Knipe New York: Raven Press, 1990:1889–1920.
[2] Callan M. F., Tan L., Annels N., Ogg G. S., Wilson J. D., O'Callaghan C. A., Steven N., McMichael A. J., Rickinson A. B. Direct visualization of antigen-specific CD8+T cells during the primary immune response to Epstein-Barr virus in vivo J. Exp. Med 1998 187, N. 9:1395–1402.
[3] Chapman A. L., Rickinson A. B. Epstein-Barr virus in Hodgkin's disease Ann. Oncol 1998 9, Suppl. 5 S 5–16.
[4] Chen F., Hu L. F., Ernberg I., Klein G., Winberg G. Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas J. Gen. Virol 1995 76, pt 1:131–138.
[5] Thorley-Lawson D. A. Epstein-Barr virus: exploiting the immune system Nat. Rev. Immunol 2001 1, N 1:75–82.
[6] Longnecker R., Kieff E. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1 J. Virol 1990 64, N 5:2319–2326.
[7] Matskova L., Ernberg I., Pawson T., Winberg G. C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signal J. Virol 2001 75, N 22:10941– 10949.
[8] Rovedo M., Longnecker R. Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn J. Virol 2008 82, N 17:8520–8528.
[9] Ingham R. J., Raaijmakers J., Lim C. S., Mbamalu G., Gish G., Chen F., Matskova L., Ernberg I., Winberg G., Pawson T. The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor J. Biol. Chem 2005 280, N 40:34133–34142.
[10] Merchant M., Longnecker R. LMP2A survival and developmental signals are transmitted through Btk-dependent and Btkindependent pathways Virology 2001 291, N 1:46–54.
[11] Swart R., Ruf I. K., Sample J., Longnecker R. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/ Akt pathway J. Virol 2000 74, N 22:10838–10845.
[12] Matskova L. V., Helmstetter C., Ingham R. J., Gish G., Lindholm C. K., Ernberg I., Pawson T., Winberg G. The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein Oncogene 2007 26, N 34:4908–4917.
[13] Winberg G., Matskova L., Chen F., Plant P., Rotin D., Gish G., Ingham R., Ernberg I., Pawson T. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases Mol. Cell. Biol 2000 20, N 22:8526–8535.
[14] Dergai M., Skrypkina I., Dergai O., Tsyba L., Novokhatska O., Filonenko V., Drobot L., Rynditch A. Identification and characterization of a novel mammalian isoform of the endocytic adaptor ITSN1 Gene 2011 485, N 2:120–129.
[15] Dergai M., Tsyba L., Dergai O., Zlatskii I., Skrypkina I., Kovalenko V., Rynditch A. Microexon-based regulation of ITSN1 and Src SH3 domains specificity relies on introduction of charged amino acids into the interaction interface Biochem. Biophys. Res. Commun 2010 399, N 2:307–312.
[16] Dergai O., Novokhatska O., Dergai M., Skrypkina I., Tsyba L., Moreau J., Rynditch A. Intersectin 1 forms complexes with SGIP1 and Reps1 in clathrin-coated pits Biochem. Biophys. Res. Commun 2010 402, N 2:408–413.
[17] Ikeda M., Longnecker R. Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability Virology 2007 360, N 2:461–468.
[18] Zarrinpar A., Bhattacharyya R. P., Lim W. A. The structure and function of proline recognition domains Sci. SRKE 2003 2003, N 179 re8.
[19] Keller S., Sanderson M. P., Stoeck A., Altevogt P. Exosomes: from biogenesis and secretion to biological function Immunol. Lett 2006 107, N 2:102–108.
[20] Yamada H., Ohashi E., Abe T., Kusumi N., Li S. A., Yoshida Y., Watanabe M., Tomizawa K., Kashiwakura Y., Kumon H., Matsui H., Takei K. Amphiphysin 1 is important for actin polymerization during phagocytosis Mol. Biol. Cell 2007 18, N 11 P. 4669–4680.
[21] Wu Y., Liang S., Oda Y., Ohmori I., Nishiki T., Takei K., Matsui H., Tomizawa K. Truncations of amphiphysin I by calpain inhibit vesicle endocytosis during neural hyperexcitation EMBO J 2007 26, N 12:2981–2990.
[22] Shang W. H., Adachi Y., Nakamura A., Copeland T., Kim S. R., Kamata T. Regulation of amphiphysin1 by mitogen-activated protein kinase: its significance in nerve growth factor receptor-mediated endocytosis J. Biol Chem 2004 279, N 39 P. 40890–40896.
[23] Peter B. J., Kent H. M., Mills I. G., Vallis Y., Butler P. J., Evans P. R., McMahon H. T. BAR domains as sensors of membrane curvature: the amphiphysin BAR structure Science 2004 303, N 5657:495–499.
[24] Lundgaard G. L., Daniels N. E., Pyndiah S., Cassimere E. K., Ahmed K. M., Rodrigue A., Kihara D., Post C. B., Sakamuro D. Identification of a novel effector domain of BIN1 for cancer suppression J. Cell. Biochem 2011 112, N 10:2992–3001.